Immetas
is a biotechnology firm that develops and commercializes novel therapeutics for the treatment of cancer and inflammatory diseases... Read moreImmetas
is a biotechnology firm that develops and commercializes novel therapeutics for the treatment of cancer and inflammatory diseases... Read more
News
Oct 13, 2023
Korea Biomedical Review
Immetas: GC and Immetas Therapeutics to co-develop autoimmune disease treatments using mRNA
Oct 12, 2023
Business Wire
Press Release: Immetas : Immetas TherapeuticsGC BiopharmamRNA
Sep 24, 2020
Global University Venturing
Immetas: Immetas measures up to $11m - Global University Venturing
